Previous 10 |
ALSN , APLE , APTS , ATH , AWR , BWXT , CDEV , CORT , CRZO , DRH , ELGX , EPR , ETSY , FRAC , FRGI , GSM , HNI , HTZ , IMMU , JBT , KAMN , KBR , LSI , MEDP , MOS , NGHC , NLS , OFIX , OKE , PBPB , PEB , PLOW , PODD , QTS , RCII , RP , RRC , SHAK , SNHY...
Intersect ENT, Inc. (Nasdaq: XENT) today announced that management will participate in the 8th Annual SVB Leerink Global Healthcare Conference on Thursday, February 28, 2019 at the Lotte New York Palace in New York City, and will present in a session at 9:30 a.m. ET. A replay of the sess...
Intersect ENT, Inc. (NASDAQ: XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today announced that it will release fourth quarter and year 2018 financial results on February 25, 2019. The company expects to issue the release at approx...
News, Short Squeeze, Breakout and More Instantly...
Data from first-of-its-kind study published in Current Medical Research and Opinion Patients receiving PROPEL ® following endoscopic sinus surgery had statistically significant lower healthcare resource utilization over a postoperative period of 18 months, including a...
Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today reported financial results for the third quarter ended September 30, 2021. Total revenue was $24.4 million for the third qu...
Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that Helios Dr. Horst Schmidt Kliniken Wiesbaden in Germany was the first hospital outside the United States to...